International safety notice
Ensayos Atellica CH: Total Bilirrubin_2 (TBil_2), LDL Cholesterol (LDLC), Gamma-Glutamyl Transferase (GGT) y HDL Cholesterol (HDLC).
Spain / AEMPS · ESP · Aug 3, 2023
Key facts
| Title | Ensayos Atellica CH: Total Bilirrubin_2 (TBil_2), LDL Cholesterol (LDLC), Gamma-Glutamyl Transferase (GGT) y HDL Cholesterol (HDLC). |
|---|---|
| Regulator | Spain / AEMPS |
| Country | ESP |
| Brand | Ensayos Atellica CH: Total Bilirrubin_2 (TBil_2), LDL Cholesterol (LDLC), Gamma-Glutamyl Transferase (GGT) y HDL Cholesterol (HDLC). |
| Manufacturer | Siemens Healthcare Diagnostics Inc. EEUU. |
| Models | 00630414595818, 91.822.52.89, 00630414611037GAMMA-GLUTAMYL, 11537214, 2023-369, 00630414595818LDL, 00630414596440, 11537213, 28022, BILIRUBIN_2, 2023-054, 1.25.4 and 12 more |
| Event type | Safety Notice |
| Date | Aug 3, 2023 |
At a glance
- No Recall
- Yes Field safety notice
- 1–9 Matching device models in FDA data
- 1–9 Matching catalog numbers in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1